| Year |
Citation |
Score |
| 2023 |
Peat TJ, Gaikwad SM, Dubois W, Gyabaah-Kessie N, Zhang S, Gorjifard S, Phyo Z, Andres M, Hughitt VK, Simpson RM, Miller MA, Girvin AT, Taylor A, Williams D, D'Antonio N, et al. Drug combinations identified by high-throughput screening promote cell cycle transition and upregulate Smad pathways in myeloma. Cancer Letters. 216284. PMID 37356470 DOI: 10.1016/j.canlet.2023.216284 |
0.453 |
|
| 2023 |
Park JE, Lee H, Oliva P, Kirsch K, Kim B, Ahn JI, Alverez CN, Gaikwad S, Krausz KW, O'Connor R, Rai G, Simeonov A, Mock BA, Gonzalez FJ, Lee KS, et al. Structural Optimization and Anticancer Activity of Polo-like Kinase 1 (Plk1) Polo-Box Domain (PBD) Inhibitors and Their Prodrugs. Acs Pharmacology & Translational Science. 6: 422-446. PMID 36926457 DOI: 10.1021/acsptsci.2c00250 |
0.343 |
|
| 2022 |
Shenoy PS, Chakraborty S, Gaikwad SM, Sakpal A, Ray P. Developing Clinically Relevant Acquired Chemoresistance Models in Epithelial Ovarian Cancer Cell Lines. Bio-Protocol. 12: e4310. PMID 35284594 DOI: 10.21769/BioProtoc.4310 |
0.542 |
|
| 2020 |
Zhang S, DuBois W, Zhang K, Simmons JK, Hughitt VK, Gorjifard S, Gaikwad S, Peat TJ, Mock BA. Mouse tumor susceptibility genes identify drug combinations for multiple myeloma. Journal of Cancer Metastasis and Treatment. 6. PMID 32923678 DOI: 10.20517/2394-4722.2020.40 |
0.349 |
|
| 2017 |
Kapoor A, Barai A, Thakur B, Das A, Patwardhan SR, Monteiro M, Gaikwad S, Bukhari AB, Mogha P, Majumder A, De A, Ray P, Sen S. Soft drug-resistant ovarian cancer cells migrate via two distinct mechanisms utilizing myosin II-based contractility. Biochimica Et Biophysica Acta. 1865: 392-405. PMID 29175377 DOI: 10.1016/J.Bbamcr.2017.11.012 |
0.726 |
|
| 2017 |
Simmons JK, Michalowski AM, Gamache BJ, DuBois W, Patel J, Zhang K, Gary J, Zhang S, Gaikwad S, Connors D, Watson N, Leon E, Chen JQ, Kuehl WM, Lee MP, et al. Cooperative Targets of Combined mTOR/HDAC Inhibition Promote MYC Degradation. Molecular Cancer Therapeutics. PMID 28522584 DOI: 10.1158/1535-7163.MCT-17-0171 |
0.441 |
|
| 2016 |
Vartak SV, Hegde M, Iyer D, Gaikwad S, Gopalakrishnan V, Srivastava M, Karki SS, Choudhary B, Ray P, Santhoshkumar TR, Raghavan SC. A Novel Inhibitor of BCL2, Disarib Abrogates Tumor Growth while Sparing Platelets, by Activating Intrinsic Pathway of Apoptosis. Biochemical Pharmacology. PMID 27693384 DOI: 10.1016/j.bcp.2016.09.028 |
0.58 |
|
| 2015 |
Shetake NG, Kumar A, Gaikwad S, Ray P, Desai S, Ningthoujam RS, Vatsa RK, Pandey BN. Magnetic nanoparticle-mediated hyperthermia therapy induces tumour growth inhibition by apoptosis and Hsp90/AKT modulation. International Journal of Hyperthermia : the Official Journal of European Society For Hyperthermic Oncology, North American Hyperthermia Group. 1-11. PMID 26416812 DOI: 10.3109/02656736.2015.1075072 |
0.399 |
|
| 2015 |
Gaikwad SM, Thakur B, Sakpal A, Singh RK, Ray P. Differential activation of NF-κB signaling is associated with platinum and taxane resistance in MyD88 deficient epithelial ovarian cancer cells. The International Journal of Biochemistry & Cell Biology. 61: 90-102. PMID 25681684 DOI: 10.1016/j.biocel.2015.02.001 |
0.667 |
|
| 2014 |
Singh RK, Gaikwad SM, Jinager A, Chaudhury S, Maheshwari A, Ray P. IGF-1R inhibition potentiates cytotoxic effects of chemotherapeutic agents in early stages of chemoresistant ovarian cancer cells. Cancer Letters. 354: 254-62. PMID 25157649 DOI: 10.1016/j.canlet.2014.08.023 |
0.663 |
|
| 2013 |
Gaikwad SM, Gunjal L, Junutula AR, Astanehe A, Gambhir SS, Ray P. Non-invasive imaging of phosphoinositide-3-kinase-catalytic-subunit-alpha (PIK3CA) promoter modulation in small animal models. Plos One. 8: e55971. PMID 23393606 DOI: 10.1371/Journal.Pone.0055971 |
0.632 |
|
| 2012 |
Gaikwad SM, Ray P. Non-invasive imaging of PI3K/Akt/mTOR signalling in cancer. American Journal of Nuclear Medicine and Molecular Imaging. 2: 418-31. PMID 23145359 |
0.606 |
|
| Show low-probability matches. |